Barbara Giesser, MD, neurologist, MS professional, Pacific Neuroscience Institute at Providence Saint John’s Health and fitness Center, Santa Monica, CA.
Gabriel Pardo, MD, director, Oklahoma Health-related Investigation Foundation’s Multiple Sclerosis Heart of Excellence, Oklahoma City.
Nationwide Several Sclerosis Society: “Adherence.”
Many Sclerosis Have confidence in (U.K.): “When Can You Safely Cease Using Condition Modifying Medicine?”
Journal of Neurology, Neurosurgery, and Psychiatry: “Discontinuing disease-modifying therapy in MS right after a extended relapse-cost-free period of time: a propensity score-matched review.”
International Journal of MS Care: “Stopping Sickness-Modifying Treatment in Nonrelapsing Multiple Sclerosis.
Affected individual-Centered Results Exploration Institute: “Can Some MS People Properly Quit Getting Medicines?”